MOLECULAR ENERGIES PLC
("Molecular" or the "Company")
Issue of Equity
Molecular Energies (AIM: MEN), the international energy company, announces that, to satisfy payment of advisory services provided to the Company, it has allotted 160,000 new Ordinary Shares of 1 pence each in the Company ("Ordinary Shares").
Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 1 February 2024.
The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 12,378,197. The Company does not hold any shares in treasury. Accordingly, the figure of 12,378,197 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For more information, please visit www.molecularenergiesplc.com or contact:
Molecular Energies PLC Peter Levine, Chairman Rob Shepherd, Group FD
|
+44 (0)20 7016 7950 |
Cavendish Capital Markets Limited (Nominated Adviser & Broker) Simon Hicks, George Dollemore
|
+44 (0)20 7220 0500 |
Tavistock (Financial PR & IR) Simon Hudson, Nick Elwes, Charles Baister |
+44 (0)20 7920 3150 |
Notes to Editors
Molecular Energies PLC is an AIM listed company at the forefront of energy development and has interests across the energy spectrum, from an oil and gas project to the green and alternative energy sector.
The Company currently has an oil exploration asset in Paraguay. The Company has two separate subdivisions which are focused on early-stage opportunities in the green and/or alternative energy sub-sector.
Activities in the green and alternative energy space are being carried out direct through Molecular and under the Green House Capital brand and through AIM listed Atome Energy PLC, a green hydrogen, ammonia, and fertiliser company operating in Paraguay, Costa Rica and Iceland, in which Molecular currently has 20.5%.
With a strong strategic and institutional base of support, no third-party financial debt and a Chairman whose interests as the largest shareholder are aligned to those of its shareholders, Molecular gives UK investors access to an energy growth story combined with world class standards of corporate governance, environmental and social responsibility.
-ends-